Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cerebral salt-wasting syndrome: does it exist?

J K Maesaka1, S Gupta, S Fishbane

  • 1Department of Medicine and Division of Nephrology and Hypertension, Winthrop University Hospital, Mineola, NY 11501, USA. jmaesaka@winthrop.org

Nephron
|June 12, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management.

British journal of pharmacology·2015
Same author

Current issues in iron management in end-stage renal disease.

Seminars in dialysis·2009
Same author

The new FDA label for erythropoietin treatment: how does it affect hemoglobin target?

Kidney international·2007
Same author

Renal salt wasting without cerebral disease: diagnostic value of urate determinations in hyponatremia.

Kidney international·2007
Same author

Refractory anemia in a patient with allergy to intravenous iron drugs.

Kidney international·2006
Same author

Targeting higher ferritin concentrations with intravenous iron dextran lowers erythropoietin requirement in hemodialysis patients.

Clinical nephrology·2003

Cerebral salt-wasting syndrome (CSWS) is distinct from SIADH, differing in fluid volume and urate excretion. Differentiating these conditions is crucial for accurate diagnosis and treatment of hyponatremia.

Area of Science:

  • Nephrology
  • Endocrinology
  • Neurology

Background:

  • Cerebral salt-wasting syndrome (CSWS) is often confused with the syndrome of inappropriate antidiuretic hormone secretion (SIADH).
  • Differentiating CSWS and SIADH is challenging due to overlapping clinical features and associated conditions.
  • Accurate assessment of extracellular volume, a key differentiator, is clinically unreliable in approximately 50% of cases.

Purpose of the Study:

  • To establish the existence and prevalence of CSWS compared to SIADH.
  • To identify reliable methods for differentiating CSWS from SIADH.
  • To investigate the role of renal salt wasting and associated factors in these syndromes.

Main Methods:

  • Analysis of serum urate and fractional excretion rates of urate in patients with hyponatremia.

Related Experiment Videos

  • Monitoring of urate levels and fractional excretion rates after water restriction therapy.
  • Review of existing literature on hyponatremic neurosurgical patients and CSWS.

    • Main Results:

    • Both CSWS and SIADH present with hyponatremia, hypouricemia, and increased fractional excretion of urate.
    • Persistent hypouricemia and elevated fractional excretion of urate after water correction indicate CSWS.
    • CSWS appears more prevalent than SIADH in neurosurgical patients, often associated with pulmonary or intracranial diseases.

    Conclusions:

    • Serum urate levels and fractional excretion rates are effective markers for distinguishing CSWS from SIADH.
    • CSWS is a distinct clinical entity, potentially more common than previously thought, especially in neurosurgical populations.
    • The term "renal salt wasting" may be more appropriate than CSWS in some cases, and a plasma natriuretic factor may be involved.